News - Eli Lilly, Healthcare


Current filters:

Eli LillyHealthcare

Popular Filters

Cardiovascular risk a concern when prescribing diabetes treatments, survey finds


Boehringer Ingelheim and Eli Lilly (NYSE: LLY) revealed that 79% of nearly 800 physicians in four Asian…

Asia-PacificBoehringer IngelheimDiabetesEli LillyHealthcarePharmaceuticalResearch

Eli Lilly initiates first international, observational study to understand barriers to progression of insulin treatment


US drug major Eli Lilly (NYSE: LLY) says it is conducting the first major international, prospective…

DiabetesEli LillyHealthcarePharmaceuticalResearch

Pfizer’s Pristiq sees private plan formulary access similar to Lilly’s Cymbalta


In the USA, similar percentages of private health plan lives have formulary access to Pfizer’s (NYSE:…

CymbaltaEli LillyHealthcareNeurologicalNorth AmericaPfizerPharmaceuticalPricingPristiq

Back to top